Rolapitant curbs chemo-induced nausea and vomiting

MADRID – The investigational neurokinin-1 receptor antagonist rolapitant met all of its endpoints in the prevention of chemotherapy-induced nausea and vomiting in a phase III trial. Among 532...

Field of Interest: Oncology
Type: News Item

Veterans at increased risk of skin cancer

EDINBURGH – U.S. military personnel deployed overseas during the past decade have increased risk factors for skin cancer, a new survey suggests. Researchers reported that 77% of veterans were...

Field of Interest: Oncology
Type: News Item

Veterans at increased risk of skin cancer

EDINBURGH – U.S. military personnel deployed overseas during the past decade have increased risk factors for skin cancer, a new survey suggests. Researchers reported that 77% of veterans were...

Field of Interest: Dermatology
Type: News Item

Cancer survivors have higher medical costs

Average annual medical expenses for male cancer survivors were more than double those of men with no history of cancer in 2008-2011, while expenditures for female cancer survivors were 64% higher...

Field of Interest: Oncology
Type: News Item

Topical lidocaine reduces menopausal dyspareunia

Applying topical liquid lidocaine to the vulvar vestibule prior to penetration allows for comfortable intercourse in breast cancer survivors with severe menopausal dyspareunia, according to findings...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.